Effectiveness of Omalizumab in Patients with Chronic Inducible Urticaria: real-life experience from two UCARE centres.
作者信息
Can P K, Salman A, Hoşgören-Tekin S, Kocatürk E
机构信息
Faculty of Medicine, Department of Dermatology, Bahçeşehir University, Istanbul, Turkey.
Department of Dermatology, Marmara University School of Medicine, Istanbul, Turkey.
出版信息
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e679-e682. doi: 10.1111/jdv.17385. Epub 2021 Jun 12.
PMID:34013560
Abstract
摘要
相似文献
1
Effectiveness of Omalizumab in Patients with Chronic Inducible Urticaria: real-life experience from two UCARE centres.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e679-e682. doi: 10.1111/jdv.17385. Epub 2021 Jun 12.
2
Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.
3
Omalizumab in chronic inducible urticaria: A retrospective, real-life study.
Ann Dermatol Venereol. 2021 Dec;148(4):262-265. doi: 10.1016/j.annder.2021.04.010. Epub 2021 Jul 8.
4
Effectiveness and tolerability of personalized omalizumab treatment in patients with chronic inducible urticaria.
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3227-3229. doi: 10.1016/j.jaip.2021.04.034. Epub 2021 Apr 26.
5
Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience.
An Bras Dermatol. 2023 Mar-Apr;98(2):240-242. doi: 10.1016/j.abd.2022.06.003. Epub 2022 Dec 23.
6
Omalizumab in children and adolescents with chronic urticaria: A 16-week real-world study.
Allergy. 2021 Apr;76(4):1271-1273. doi: 10.1111/all.14686. Epub 2020 Dec 18.
7
[HOW PERIPHERAL BASOPHILS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA ARE CHANGED WITH OMALIZUMAB TREATMENT?].
Arerugi. 2021;70(9):1196-1199. doi: 10.15036/arerugi.70.1196.
8
Chronic spontaneous urticaria treated with omalizumab: what differentiates early from late responders?
Eur Ann Allergy Clin Immunol. 2021 Jan;53(1):47-48. doi: 10.23822/EurAnnACI.1764-1489.147. Epub 2021 Jan 7.
9
High-dose omalizumab use in patients with chronic spontaneous urticaria.
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1426-1427.e1. doi: 10.1016/j.jaip.2019.10.018. Epub 2019 Oct 31.
10
"Omalizumab plus": Combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: A multicenter UK series.
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1400-1401.e2. doi: 10.1016/j.jaip.2020.10.056. Epub 2020 Nov 9.
引用本文的文献
1
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.
Allergy. 2025 Feb;80(2):489-499. doi: 10.1111/all.16334. Epub 2024 Oct 8.
Zotero 插件